tradmap

ICCC IMMUCELL CORP /DE/

$9.46 +0.53%

Healthcare · In Vitro & In Vivo Diagnostic Substances

IMMUCELL CORP /DE/ (ICCC) is a healthcare company in the In Vitro & In Vivo Diagnostic Substances industry, with a market capitalization of $86 million. Shares last traded at $9.46, 22.4% below their 52-week high. Over the past year the stock is up 76.1%. Net profit margin is -3.8%, in line with the peer median of -3.8%. Revenue grew 4.3% year over year.

Market Cap
$86M
Shares Out
9.0M
EPS (TTM)
$0.79
P/E Ratio
11.97
P/S Ratio
3.09
P/B Ratio
2.94
Dividend / Share
Dividend Yield
52-Week High
$12.19
52-Week Low
$4.57
Volume
457
Avg Vol (3m)
530.952

Performance

1W
-3.03%
1M
-7.30%
3M
+43.47%
6M
+55.00%
YTD
+58.24%
1Y
+76.07%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
50.65
SMA (50)
$8.79
SMA (200)
$6.82
Price vs SMA50
+7.58%
Price vs SMA200
+38.54%
ATR (14)
$0.33

Financials

Revenue
$28M
Net Income
$-1M
Gross Margin
41.4%
Operating Margin
6.0%
Net Margin
-3.8%
Return on Equity
-3.6%
Return on Assets
-2.4%
Current Ratio
4.82
Debt / Equity
0.30
Revenue Growth (YoY)
+4.3%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $0.21 2026-05-14
FY 2025 $-0.12 2026-03-30
Q3 2025 $0.20 2025-11-13
Q2 2025 $0.22 2025-08-14
Q1 2026 $0.16 2026-05-14
FY 2025 $-0.26 2026-03-30

Full earnings history →

In Vitro & In Vivo Diagnostic Substances peers

ICCC vs 14 industry peers (In Vitro & In Vivo Diagnostic Substances), by market cap.

P/S vs peers
3.09 / 4.39 med
-29% discount
Net margin vs peers
-3.8% / -3.8% med
above median
1–14 of 14
IDXXIdexx Laboratories$44.3B41.8410.3024.6%+2.91%
LNTHLantheus Holdings, Inc.$6.8B28.974.3915.2%+0.67%
CLDXCelldex Therapeutics, Inc.$2.5B-9.84-1.47%
NTLAIntellia Therapeutics, Inc.$2.2B-5.30+2.25%
NEOGNeogen Corp$2.0B-1.85+4.14%
QDELQuidelortho Corp$932M+4.27%
ACHVAchieve Life Sciences, Inc.$496M-9.07-9.72%
MYGNMyriad Genetics Inc$429M-1.170.52-44.4%+3.65%
TKNOAlpha Teknova, Inc.$282M-16.326.95-42.6%+6.38%
IMDXInsight Molecular Diagnostics Inc.$176M-3510.5043.48-1.2%+2.25%
ICCCIMMUCELL CORP /DE/$86M-82.253.09-3.8%+0.53%
QCLSQ/C TECHNOLOGIES, INC.$32M-2.72+4.28%
VNRXVOLITIONRX LTD$12M-0.52+6.14%
CDIOCardio Diagnostics Holdings, Inc.$6M+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.